A look at how the trade war could affect profits.
Citigroup (C) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
President Donald Trump's sweeping tariffs have sent the market into free fall and it's clear investors are starting to panic as they think about the adverse effects of a transitioning economy, slower
Citigroup (C) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Large-capitalization blue-chip dividend stocks are a favorite among investors for a good reason.

Bank stocks extend losses over recession fears

10:54am, Friday, 04'th Apr 2025
CNBC's Leslie Picker joins CNBC's 'Squawk on the Street' to discuss why financials are down since the announcement of tariffs.
Shares of C, BAC, MS, GS and WFC took a heavy hit on Thursday's trading session after Trump announced sweeping tariffs, raising recession risks.

Citigroup Declares Common Stock Dividend

08:01pm, Thursday, 03'rd Apr 2025
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Citigroup Inc. today declared a quarterly dividend on Citigroup's common stock of $0.56 per share, payable on May 23, 2025, to stockholders of reco
NEW YORK--(BUSINESS WIRE)--Citigroup Inc. is announcing the redemption, in whole, constituting $3,500,000,000 of its 3.106% Fixed Rate / Floating Rate Notes due 2026 (the “notes”) (ISIN: US172967M
Citigroup is undervalued, trading at 0.79x tangible book value, presenting a potential long-term investment if Jane Fraser's restructuring plan succeeds. Despite weak sentiment and regulatory issues,
The stock market was having its worst day in years on Thursday after President Trump announced tariffs on more than 180 countries that were far worse than expected. As of 1 p.m.
FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunot
Citigroup's (C) cost-cutting measures, technology modernization, and strategic exits have led to tangible improvements, positioning it as a "buy" despite macroeconomic challenges. C's strong CET1 and
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE